Biocrossroads News Archives - Page 4 of 6 - The Central Indiana Corporate Partnership

BioCrossroads’ seed capital strategy connects funding with innovation

Raquel Bahamonde2021-10-27T18:20:35-04:00October 27, 2021|

INDIANAPOLIS (Oct. 27, 2021) — For nearly 20 years, BioCrossroads has demonstrated a track record of organizing, developing and managing seed-stage and venture capital funds for Indiana-based life sciences start-ups. BioCrossroads’ three Indiana Seed Funds, totaling $24.25 million, have invested in 32 life sciences start-ups since 2006. Those companies have gone on to raise an additional $796 million, more than 33 times BioCrossroads’ initial investment. A new report: Supporting Life Sciences: A look back at BioCrossroads’ capital strategy details the investment results of these three investment funds that have provided important capital to Indiana’s life sciences start-ups over the last 15 years. The analysis looks at the impact of BioCrossroads’ capital strategy, which includes the development of: $6 million Indiana Seed Fund I in 2006 $8.25 million Indiana Seed Fund II in 2012, and $9 million Indiana Seed Fund III in [...]

Purdue chemistry professor and founder of Inotiv, Dr. Peter Kissinger, honored as 2021 Watanabe Life Sciences Champion of the Year

Raquel Bahamonde2021-10-14T10:57:41-04:00October 13, 2021|

INDIANAPOLIS (Oct. 13, 2021) — BioCrossroads’ Board of Directors named educator, innovator and researcher Dr. Peter Kissinger as the recipient of the 2021 August M. Watanabe Life Sciences Champion of the Year Award. The prestigious honor, named in tribute to BioCrossroads’ late Chairman August Watanabe, was given to Dr. Kissinger at today’s Indiana Life Sciences Summit. His research has helped patients around the world, and his leadership has contributed to the Indiana life sciences community. An academic, researcher and entrepreneur, Dr. Kissinger is highly recognized for his pioneering work in sophisticated techniques for drug development. He taught at Purdue University for more than 40 years, influencing thousands of students. He has helped guide multiple startup companies, including Prosoila, Phlebotics, Animated Dynamics, and Tymora Analytical. Kissinger teams have enabled painless sampling of laboratory animals that both sped up drug development and reduced the [...]

New report highlights outsized impact of healthcare and life sciences sector in Central Indiana

Raquel Bahamonde2021-08-25T12:50:39-04:00August 25, 2021|

INDIANAPOLIS (August 25, 2021) – Central Indiana’s1 healthcare and life sciences sector has an $84 billion annual economic impact and directly employs more than 133,000 people and 331,000 workers indirectly, according to a new report. The study from TEConomy Partners, ESSENTIAL: The economic impact of Central Indiana’s healthcare and life sciences sector, examined the influence of decades of investments in the region as well as how the sector provides benefits to Indiana’s other industries such as manufacturing, technology and retail. The report discusses not only the economic measures of capital expenditures, wages and jobs, but also analyzes the non-traditional impacts such as access to healthcare and its influence on economic development. It also points out that the healthcare and life sciences ecosystem is larger than traditional research and development, underscoring the importance of continued investment in the sector. Key statistics [...]

2021 Indiana Life Sciences Summit features global life sciences and healthcare leaders

Raquel Bahamonde2021-08-04T08:38:13-04:00August 4, 2021|

INDIANAPOLIS (August 4, 2021) – BioCrossroads 2021 Virtual Indiana Life Sciences Summit will feature global life sciences and healthcare thought leaders who will discuss how inclusion and collaboration have changed in the two industries over the last year. The conference is Wednesday, Oct. 13 and the live stream kicks off at 10:00 a.m. Life sciences and healthcare industry speakers include: Dr. Freda Lewis-Hall, former chief patient officer and executive vice president of Pfizer, Inc./consultant at PhRMA Dr. Virginia A. Caine, director, Marion County Public Health Department Dennis Murphy, president and CEO, IU Health Dr. Peter Kim, director, Therapeutics Research Program, Division of AIDS, National Institute of Allergy and Infectious Disease, National Institutes of Health Dr. Anthony Philippakis, chief data scientist, Broad Institute Dr. Richard DiMarchi, distinguished professor of Chemistry and Gill Chair in Biomolecular Sciences, Indiana University Keynotes will be [...]

Indiana’s life sciences companies accessed more than $9 billion to grow innovation in 2020 BioCrossroads report details funding sources, deals, investors

Raquel Bahamonde2021-05-05T06:36:06-04:00April 12, 2021|

INDIANAPOLIS (April 12, 2021) -- In 2020, Indiana’s life sciences companies accessed over $9 billion in capital to grow and support innovation. The funding comes from a variety of sources including Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) awards, venture capital, initial public offerings and related public offerings, and mergers and acquisitions. BioCrossroads today issued their annual report, Indiana Life Sciences Capital 2020, which provides details on the funding events throughout the year. The $9 billion includes: $12.6 million SBIR awarded to 21 companies. $262 million in venture capital invested in 44 companies. $141.8 million accessed through public markets by three companies. $8.6 billion+ spent to acquire innovation, representing nine transactions. The market capitalization for Indiana’s public life sciences companies as of Dec. 31, 2020 was $297.6 billion and includes Eli Lilly and Company, Anthem, Zimmer [...]

Indiana’s life sciences industry breaks yearly records in two key categories – exports and venture capital

Raquel Bahamonde2021-04-21T11:21:42-04:00March 25, 2021|

INDIANAPOLIS, (March 25, 2021) -- While COVID-19 continues to make the headlines, Indiana’s life sciences industry not only combatted the pandemic with testing, treatments, clinical trials, and vaccine manufacturing but remained committed to innovating and investing throughout 2020. New data provided to BioCrossroads by the Indiana Business Research Center (IBRC) at the Indiana University Kelley School of Business shows a thriving and growing sector. One of the most notable milestones: Indiana is the second highest exporter of life sciences products in the U.S. and has been for more than a decade. In 2020, more than $11.4 billion of products were exported from the state, representing more than $192,000 of output per worker, the highest amount ever recorded. In addition, Indiana life sciences start-ups garnered a record level of venture capital investment with more than $262 million committed to 44 companies, [...]

BioCrossroads report underscores importance of strong tech transfer programs at Indiana’s research universities

Raquel Bahamonde2021-04-05T16:47:42-04:00November 19, 2020|

INDIANAPOLIS, (Nov. 19, 2020) -- BioCrossroads today released a new report, Tech Transfer in Indiana: An Overview for the Life Sciences Industry, a comprehensive resource highlighting the technology transfer processes and approaches used by Indiana University, Purdue University and the University of Notre Dame to facilitate commercialization of research-driven discoveries and innovations. The report also discusses the role of incubators and graduation facilities at research universities, which are increasing in number and importance. “With our three research institutions and thousands of research faculty, Indiana has critical assets necessary to drive innovation. University labs and facilities are especially important for life sciences R&D that require unique space and equipment required to perform complex research,” said Patricia Martin, president and CEO, BioCrossroads. In addition to developing breakthroughs in medical treatments and therapies, Indiana’s three R11 research institutions also generate a substantial amount of [...]

Richard M. Fairbanks Foundation grants BioCrossroads funding to advance collaborative and educational life sciences initiatives

Raquel Bahamonde2021-04-05T16:47:42-04:00October 29, 2020|

INDIANAPOLIS (Oct. 29, 2020) -- BioCrossroads announced today that the Richard M. Fairbanks Foundation has made a grant of $1.35 million to the organization to continue to advance the strength and opportunities of several collaborative and educational initiatives within Indiana’s life sciences sector. The Fairbanks Foundation is an Indianapolis-based, independent, private foundation focused on the education, health and the vitality of the Indianapolis community. “The life sciences sector is a key driver of Indiana’s economy, accounting for 20% of the state’s GDP. BioCrossroads plays a critical role helping to create an environment in which this sector can flourish,” said Claire Fiddian-Green, president and CEO of the Richard M. Fairbanks Foundation. “We are pleased to provide continued support for the organization and its key initiatives.” The two-year grant enables BioCrossroads to continue to advance Indiana’s vitality in the life sciences via [...]

Indiana’s premier drug development and manufacturing sector adds another company to its ecosystem

Raquel Bahamonde2021-04-05T16:47:43-04:00October 15, 2020|

INCOG BioPharma Services, Inc. announced plans to build new facility in Fishers, Ind., add 150 new jobs INDIANAPOLIS (Oct. 15, 2020) - Indiana is one of the premier contract drug development and manufacturing centers in the United States. These pharmaceutical contract service providers support the growing outsourcing needs of both large pharmaceutical and smaller biotechnology companies. Nearly 40 contract research and manufacturing organizations employ more than 7,000 workers throughout the state. Companies like Covance Central Labs (Indianapolis), Catalent Biologics (Bloomington) and B2S Life Sciences (Franklin) provide pre-clinical testing, toxicology, product manufacturing and other support to pharmaceutical companies worldwide. Pharmaceutical and biotechnology companies would not be able to discover, develop and distribute their products without these important partners. This week, INCOG BioPharma announced that they are forming a new biopharmaceutical manufacturing company in Fishers, Ind. Formed by an experienced management team, [...]

Developer of Echocardiography Dr. Harvey Feigenbaum honored as BioCrossroads 2020 Life Sciences Champion of the Year

Raquel Bahamonde2021-04-05T16:47:43-04:00October 7, 2020|

INDIANAPOLIS (Oct. 7, 2020) — BioCrossroads’ Board of Directors named esteemed “Father of Echocardiography” (Echo) Dr. Harvey Feigenbaum, as the recipient of the 2020 August M. Watanabe Life Sciences Champion of the Year Award. The prestigious honor, named in tribute to BioCrossroads’ late Chairman August Watanabe, was given to Dr. Feigenbaum at today’s Indiana Life Sciences Summit for his unprecedented impact on cardiac health in Indiana and around the world. Dr. Feigenbaum is recognized for pioneering the Echo, the most widely used cardiac imaging technique in the world. Dr. Feigenbaum has made numerous contributions to the medical profession that include developing the world’s first practical, long lasting use of echocardiography, the use of ultrasound to examine the heart, in 1965. He fought and overcame many years of skepticism by training many early world-wide pioneers in echocardiography and the first cardiac sonographer. [...]

MAIN MENU

IMPORTANT LINKS

INITIATIVES